Paris Abstracts answers. A clustered multivariate regression analysis explored theoretical validity of results. RESULTS: On average, respondents are willing to pay a12,920 (VAS scores) and a24,549 for a QALY (EuroQoL tariffs). Subgroup analysis showed great variation in WTP/QALY between income groups-from a5,000 in the lowest to a87,000 for a QALY in the highest group. Respondents that indicated a high level of certainty exhibited marginally higher WTP. Regression analyses showed a consistent relationship between income, other demographics and WTP/QALY. CONCLUSIONS: Individual WTP/QALY should be seen as a step to a sound empirical value of the social cost-effectiveness threshold in the Netherlands. Estimates elicited in this study are similar to those found in other empirical studies and are systematically lower than often cited thresholds, largely unsupported by empirical evidence (i.e. $50,000). However, there is a wide gap between the social and private value of a QALY. Future research should move towards estimating the social value of the cost-effectiveness threshold and align with the perspective of decision-makers thus creating a truly valuable decision-making tool. OBJECTIVES: Innovative point-of-care diagnostics are likely to be having a strong impact on health care. The aim of this study is to conduct an early assessment of he aim of this study is to conduct an early assessment of point-of-care chips. These chips can detect many particles and, consequently, many product-market combinations can be developed. This study investigates the impact of potential point-of-care applications in health care and to quantify the impact in terms of their likely cost-effectiveness. METHODS: The Analytic Hierarchy Process (AHP);
a technique for multi-criteria analysis, and Markov modeling were applied in this early assessment. The AHP was used to prioritize six potentially attractive product-market combinations (PCM's). For estimating the future cost-effectiveness of the most attractive PMC's, Markov health state transition models were developed. Two Markov models were constructed; models for a potassium chip for both stage 5 CKD patients as well as heart failure (HF) patients which suffer from edemas. RESULTS: AHP identified clinical gain as being the most important criterion to assess the attractiveness of a PMC, followed by market potential, attitude of professionals, R&D barriers and implementation barriers. Regarding these criteria, a potassium-chip for Chronic Kidney Disease (CKD) and Heart Failure (HF) patients was calculated to be the most attractive alternative. Markov model cohort simulation yielded incremental cost-effectiveness ratios (ICERs). The point-of-care chip appeared not to be cost-effective for preventing hyperkalemia in stage 5 CKD patients. For HF patients suffering from edemas the chip was estimated to be cost-effective and could provide a valuable asset to current treatment. CONCLUSIONS: The AHP is valuable in supporting the identification of potentially attractive product-market combinations. For the best combinations, Markov modeling can subsequently provide a more in-depth analysis of the future cost-effectiveness.
PHP48 A NEW TEST OF THE CARERQOL INSTRUMENT: MEASURING 'CARE-RELATED QUALITY OF LIFE' OF INFORMAL CAREGIVERS FOR USE IN ECONOMIC EVALUATIONS
Hoefman RJ, Exel NJA, Redekop WK, Brouwer WBF ErasmusMC, Rotterdam, The Netherlands OBJECTIVES: At present the costs and effects of providing informal care are often ignored in economic evaluations. This is problematic since considering informal This is problematic since considering informal since considering informal care a 'zero cost' substitute for formal care may result in non-optimal decisions from may result in non-optimal decisions from in non-optimal decisions from a societal perspective, at the burden of carers. This study further investigates the validity of the CarerQol instrument, which values the full impact of informal care on caregivers. The CarerQoL consists of seven burden dimensions (CarerQol-7D) ists of seven burden dimensions (CarerQol-7D) and a visual analogue scale measuring happiness (CarerQol-VAS). METHODS: A questionnaire was distributed by mail among a sample of caregivers (n 1100) 1100) via regional support centres for informal caregivers throughout the Netherlands. Construct validity (n 249) was tested with Spearman's correlation coefficients of 249) was tested with Spearman's correlation coefficients of the CarerQol-VAS and the CarerQol-7D and two measures of subjective burden and the utility of care giving. Clinical validity was evaluated by the multivariate cor-y the multivariate correlation between the CarerQol-VAS and characteristics of the caregiver, care recipient and care situation. Differences in CarerQol-VAS scores among caregivers are explained with subgroup multiple linear regression analyses and principal component analyses. RESULTS: CarerQol-VAS scores were negatively associated with burden and positively with utility of caring. The seven dimensions of the CarerQol-7D were also associated with burden and utility of caring in the expected direction, for six dimen-six dimensions the associations were statistically significantly. Significant associations with CarerQol-VAS scores were found for a range of characteristics, including duration and intensity of care, relationship between carer and patient, carer education level and patient age. CONCLUSIONS: Our results further support the construct and clinical validity of the CarerQol and thus underlines the relevance of this instrument for including informal care effects in economic evaluations. The next, necessary step in the development of the CarerQol concerns the establishment of tariffs for the in the development of the CarerQol concerns the establishment of tariffs for the caring situations defined by the seven dimensions. This is the topic of coming defined by the seven dimensions. This is the topic of coming research.
PHP49 PALLIATIVE CARE AND ITS REIMBURSEMENT FOR OUTPATIENT SERVICES IN GERMANY-A SURVEY AMONG OFFICE-BASED PHYSICIANS
Prenzler A 1 , Mittendorf T 1 , Kuchenbecker U 2 , Montag T 3 , Mueller-Busch C 4 1 Leibniz University of Hannover, Hannover, Germany, 2 Wyeth Pharma, Muenster, Germany, 3 University hospital of Cologne, Cologne, Germany, 4 German Association of Palliative Medicine, Berlin, Germany OBJECTIVES: To assess the provision of health care and reimbursement in ambulatory palliative care in Germany. METHODS: A survey was conducted among 1000 office-based physicians in January 2009, covering e.g. the following topics: quantity of palliative care, its reimbursement and resource use due to side effects of opioid medication. RESULTS: A total of 314 physicians (30% response rate) were included in the statistical analysis. A total of 63.7% were general practitioners (GP), 36.3% specialists. A total of 67% of all physicians were additionally trained in palliative medicine. Fifty percent estimate efforts associated with palliative care to be at least 1.5 times higher compared to patients with other serious conditions. On average GPs (specialists) visit palliative patients 5.9 (3.7) times per quarter at home (2.3 (1.2) visits for non-palliative though sick patients, p 0.01). Overall palliative patients also require more office consultations compared to nonpalliative patients (4.6 vs. 3.5, GP 4.7 vs. 3.5, specialist 4.5 vs. 3.4, all p 0.01) and need more time per visit (17.5 min versus 11.5 min) (p 0.01). Constipation is the most frequent side-effect in opioid medication and requires app. 20% more time and effort compared to no constipation. According to the German Remuneration Scheme (EBM) GPs (specialists) receive a lump-sum per quarter for office consultations, irrespective of number or length of visit or palliative status, of app. a35 (31) and a mean of app. a7.50 (7) for a basic consultation. Hence, 95% (60%) of the participants trained in palliative care evaluate the reimbursement and health care structures in the German setting as insufficient or very insufficient. CONCLUSIONS: Compared to non-palliative there is a higher need for medical resources among palliative patients-a need that is currently not reflected in the remuneration system. Considering the demographic development and the resulting significance of palliative care further research should focus on identifying room for improvement and corresponding strategies.
PHP51 51 ASSESSMENT OF PRESCRIPTION DRUG KNOWLEDGE AND THE IMPACT OF COUNSELING ON IT IN PATIENTS VISITING A PUBLIC TEACHING HOSPITAL IN NORTH INDIA
Kachhadiya R 1 , Ethiraj D 1 , Tiwari P 2 , Gautam C 3 1 NIPER, Mohali, Punjab, India, 2 NIPER, Mohali, India, Mohali, Punjab, India, 3 Government Medical College and Hospital, Chandigarh, Punjab, India OBJECTIVES: To assess the prescription drug knowledge and the impact of counseling on it in patients visiting a public teaching hospital. METHODS: A standardized questionnaire of prescription drug knowledge that embraces 8 questions e.g. drug name, indication, side effect, dose, frequency of dosing, dosage schedule, storage and missed dose action of prescription drugs was used. Education level was set as group-1 illiterate patients, group-2 education up to secondary school and group-3 graduate patients. The patients were scored 1 for every correct answer, with a maximum of 8. The overall scores were then categorized as low ( 3), medium (3-6) and high ( 6). Patients were counseled by oral, written, oral-pictorial combine, written-pictorial combine and oral-written-pictorial combine for all the questions. Post counseling evaluation was performed to assess the impact of patient counseling. RESULTS: Total 753 patients were assessed. Patient's knowledge about prescription drug name, side effect, dose and missed dose action was poor. The prescription drug knowledge score was low ( 3) in group-1 and the patients of acute drug treatment. Whereas, medium (3-6) knowledge score was observed in group-2, group-3 and patients of chronic drug treatment. The overall score was improved from 3.43 1.47 to 6.20 1.47 to 6.20 1.26 after 1.26 after counseling in all enrolled patients. After counseling overall score was improved from 2.88 1.40 to 6.01 1.40 to 6.01 1.16 and from 3.71 1.16 and from 3.71 1.43 to 6.30 1.43 to 6.30 1.29 in patients of acute 1.29 in patients of acute and chronic drug treatment, successively. Improvement in overall score was observed from 2.78 1.37 to 5.55 1.37 to 5.55 1.19, from 3.52 1.19, from 3.52 1.10 to 6.32 1.10 to 6.32 0.88 and from 4.49 0.88 and from 4.49 1.55 to 7.25 1.17 in educational group-1, group-2 and group-3 after counseling, 1.17 in educational group-1, group-2 and group-3 after counseling, respectively. CONCLUSIONS: Patients having low level of education, acute drug treatment and especially female patients know little about their prescribed drugs. Patient counseling about their prescribed drugs will help to improve the patient's compliance and may lead to achieve better patient outcome.
PHP52 AN EVALUATION OF THE POLICY AND THE PROCEDURES OF SUCCESSFUL PHARMACEUTICAL EXPORTERS AND THE COMPARISON IRANIAN COUNTERPART POLICY
Seyedifar/Meysam MS Tehran University of Medical Science, Tehran, Iran, Iran OBJECTIVES: The purpose of the current study is to evaluate the pharmaceutical industries' situation and the effective factors in pharmaceutical products exportation in successful exporting countries and to compare the results with the situation of pharmaceutical industries in Iran and the factors affecting their exportation experiences. METHODS: For the purposes of current cross-sectional study, an analytic questionnaire with open ended questions was designed which consisted of 32 questions in 8 fields. Subjects of the study consisted of 20 experts and officeholders of pharmaceutical industries and pharmaceutical products exporting companies and relevant governmental sections. Relevant information regarding pharmaceutical industries and
